BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2008
View Archived Issues
LOR-253 induces cancer cell cycle arrest in preclinical studies
Read More
CK2 protein kinase inhibitor shows antitumor activity in preclinical studies
Read More
Novartis rounds up Q1 developments
Read More
DEBIO-025 enhances antiviral effect of pegylated interferon alpha-2a in HCV patients
Read More
PF-03732010 active in vivo against P-cadherin-expressing cancers
Read More
Small-molecule inhibitors of Cdc7 kinase developed at Nerviano Medical Sciences
Read More
Progen reports synthesis of novel heparan sulfate mimetics
Read More
Alexza completes enrollment in phase IIa AZ-002 trial in panic disorder
Read More
Cleveland BioLabs presents update on the company's 2008 activities
Read More
ImmuneRegen to supply adjuvant to DynPort for Venezuelan equine encephalitis vaccine
Read More
Critical Therapeutics signs merger agreement with Cornerstone BioPharma
Read More
Accentia reports results from pivotal phase III trial of SinuNase for chronic sinusitis
Read More
3M and Infectious Disease Research Institute collaborate on vaccine adjuvants
Read More
Sepracor acquires Oryx and expands commercial operations into Canada
Read More
Sepracor and Arrow sign agreement to enhance ciclesonide and Brovana
Read More
Discovery Labs receives FDA approvable letter for Surfaxin
Read More
Oncothyreon files IND with the FDA for PX-866 for advanced cancers
Read More
Pro-Pharmaceuticals updates NDA filing plan for Davanat
Read More
AstraZeneca files marketing application for Iressa in Europe
Read More
Mologen receives approval for phase I MGN-1703 clinical study in cancer
Read More
Renovis stockholders approve adoption of the merger agreement with Evotec
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More
Novel antithrombotic agents reported in recent patents
Read More
Recent Synta patent reports novel immunosuppressant agents
Read More